PLAIO, established in 2021, is a dynamic player positioned at the intersection of the pharmaceutical and technology sectors. Headquartered in Iceland, the company has rapidly emerged as an innovative force with its slogan, "Pharma supply chain software built for end-to-end planning through Demand, Supply and Production."
This B2B SaaS platform leverages artificial intelligence to transform the way pharmaceutical supply chains operate. By providing an advanced visual planning tool, PLAIO empowers supply managers to anticipate and optimize manufacturing needs, ensuring efficiency and reducing waste. Their solution addresses a critical bottleneck in the pharmaceutical industry, appealing to a broad spectrum of stakeholders.
Recently, PLAIO secured an Early VC investment on October 1, 2025, with participation from Sikich. This infusion of capital underlines investor confidence in their growth potential and technological prowess. The company stands poised to expand its market reach and further refine its platform, making it an appealing prospect for future investment rounds.